275 related articles for article (PubMed ID: 31030263)
21. NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage.
D'Amico AG; Maugeri G; Rasà D; Federico C; Saccone S; Lazzara F; Fidilio A; Drago F; Bucolo C; D'Agata V
J Cell Physiol; 2019 Apr; 234(4):5230-5240. PubMed ID: 30374973
[TBL] [Abstract][Full Text] [Related]
22. Connexin43 in retinal injury and disease.
Danesh-Meyer HV; Zhang J; Acosta ML; Rupenthal ID; Green CR
Prog Retin Eye Res; 2016 Mar; 51():41-68. PubMed ID: 26432657
[TBL] [Abstract][Full Text] [Related]
23. Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.
Trudeau K; Roy S; Guo W; Hernández C; Villarroel M; Simó R; Roy S
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6348-54. PubMed ID: 21715349
[TBL] [Abstract][Full Text] [Related]
24. Caffeine Prevents Blood Retinal Barrier Damage in a Model, In Vitro, of Diabetic Macular Edema.
Maugeri G; D'Amico AG; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Biochem; 2017 Aug; 118(8):2371-2379. PubMed ID: 28106278
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/ PI3K signaling.
Garcia-Ramírez M; Hernández C; Ruiz-Meana M; Villarroel M; Corraliza L; García-Dorado D; Simó R
Cell Signal; 2011 Oct; 23(10):1596-602. PubMed ID: 21620963
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
[TBL] [Abstract][Full Text] [Related]
27. TNF-α released from retinal Müller cells aggravates retinal pigment epithelium cell apoptosis by upregulating mitophagy during diabetic retinopathy.
Liu Y; Li L; Pan N; Gu J; Qiu Z; Cao G; Dou Y; Dong L; Shuai J; Sang A
Biochem Biophys Res Commun; 2021 Jul; 561():143-150. PubMed ID: 34023779
[TBL] [Abstract][Full Text] [Related]
28. Protective Effect of Curcumin on the Tight Junction Integrity and Cellular Senescence in Human Retinal Pigment Epithelium of Early Diabetic Retinopathy.
Cheng YW; Huang YC; Chang KF; Huang XF; Sheu GT; Tsai NM
J Physiol Investig; 2024 May; 67(3):107-117. PubMed ID: 38857204
[TBL] [Abstract][Full Text] [Related]
29. High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells.
Villarroel M; García-Ramírez M; Corraliza L; Hernández C; Simó R
Endocrinol Nutr; 2009 Feb; 56(2):53-8. PubMed ID: 19627712
[TBL] [Abstract][Full Text] [Related]
30. IL-10-induced modulation of macrophage polarization suppresses outer-blood-retinal barrier disruption in the streptozotocin-induced early diabetic retinopathy mouse model.
Lee SJ; Noh SE; Jo DH; Cho CS; Park KS; Kim JH
FASEB J; 2024 May; 38(9):e23638. PubMed ID: 38713098
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of hemopexin in the diabetic eye: a new pathogenic candidate for diabetic macular edema.
Hernández C; Garcia-Ramírez M; Simó R
Diabetes Care; 2013 Sep; 36(9):2815-21. PubMed ID: 23620477
[TBL] [Abstract][Full Text] [Related]
32. Sodium Tanshinone IIA Silate Alleviates High Glucose Induced Barrier Impairment of Human Retinal Pigment Epithelium through the Reduction of NF-κB Activation via the AMPK/p300 Pathway.
Guo ZL; Li Y; Liu XW; Wu MY; Guo Q; Yao XC; Wang YD; Wu WY
Curr Eye Res; 2020 Feb; 45(2):177-183. PubMed ID: 31576759
[No Abstract] [Full Text] [Related]
33. Characteristics of Hemichannel-Mediated Substrate Transport in Human Retinal Pigment Epithelial Cells under Deprivation of Extracellular Ca
Maruyama S; Akanuma SI; Kubo Y; Hosoya KI
Biol Pharm Bull; 2020; 43(8):1241-1247. PubMed ID: 32741944
[TBL] [Abstract][Full Text] [Related]
34. Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy.
Mugisho OO; Green CR; Zhang J; Acosta ML; Rupenthal ID
Drug Discov Today; 2019 Aug; 24(8):1627-1636. PubMed ID: 30690195
[TBL] [Abstract][Full Text] [Related]
35. Synergic effects of EP2 and FP receptors co-activation on Blood-Retinal Barrier and Microglia.
Nakamura N; Honjo M; Yamagishi R; Sakata R; Watanabe S; Aihara M
Exp Eye Res; 2023 Dec; 237():109691. PubMed ID: 37884204
[TBL] [Abstract][Full Text] [Related]
36. Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.
Mugisho OO; Aryal J; Shome A; Lyon H; Acosta ML; Green CR; Rupenthal ID
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835288
[TBL] [Abstract][Full Text] [Related]
37. Measuring permeability in human retinal epithelial cells (ARPE-19): implications for the study of diabetic retinopathy.
Garcia-Ramírez M; Villarroel M; Corraliza L; Hernández C; Simó R
Methods Mol Biol; 2011; 763():179-94. PubMed ID: 21874452
[TBL] [Abstract][Full Text] [Related]
38. TNF-α disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium.
Shirasawa M; Sonoda S; Terasaki H; Arimura N; Otsuka H; Yamashita T; Uchino E; Hisatomi T; Ishibashi T; Sakamoto T
Exp Eye Res; 2013 May; 110():59-69. PubMed ID: 23454586
[TBL] [Abstract][Full Text] [Related]
39. Caspase-14 expression impairs retinal pigment epithelium barrier function: potential role in diabetic macular edema.
Beasley S; El-Sherbiny M; Megyerdi S; El-Shafey S; Choksi K; Kaddour-Djebbar I; Sheibani N; Hsu S; Al-Shabrawey M
Biomed Res Int; 2014; 2014():417986. PubMed ID: 25121097
[TBL] [Abstract][Full Text] [Related]
40. Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels.
Kim Y; Griffin JM; Nor MNM; Zhang J; Freestone PS; Danesh-Meyer HV; Rupenthal ID; Acosta M; Nicholson LFB; O'Carroll SJ; Green CR
Neurotherapeutics; 2017 Oct; 14(4):1148-1165. PubMed ID: 28560708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
